Clinical and economic research of bone modifiers as adjuvant therapy for early breast cancer: A systematic literature review
Many unresolved issues remain regarding bone modifiers in EBC adjuvant therapy. Insufficient clinical and economic evidence precludes drawing comprehensive conclusions at present. Future studies need to provide higher-quality evidence to deepen our understanding of adjuvant therapy with bone modifiers.
Authors
- Jiaqin Cai (ORCID: https://orcid.org/0000-0002-8223-3187)
- Lirong Zhang (ORCID: https://orcid.org/0000-0001-7466-1029)
- Xiaoxia Wei (ORCID: https://orcid.org/0000-0003-2443-1203)
- Lina Zhu (ORCID: https://orcid.org/0000-0002-8558-2120)
- Hong Sun (ORCID: https://orcid.org/0000-0001-6863-9327)
- Suyan Liu (ORCID: https://orcid.org/0000-0001-7421-1239)
- Huiting Lin (ORCID: https://orcid.org/0000-0001-5793-9631)
- Jia Liu (ORCID: https://orcid.org/0009-0007-7548-6147)
- Wenhua Wu
Institutions
- Fujian Medical University (CN)
- Fujian Provincial Hospital (CN)
Publication Details
- Journal
- The Breast
- Published
- 2025-08-08
- DOI
- https://doi.org/10.1016/j.breast.2025.104551
- Primary Topic
- Bone health and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00